Photosensitizing and Radiosensitizing Effects of Hypericin on Human Renal Carcinoma Cells in Vitro
- 5 November 2007
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 84 (1), 228-235
- https://doi.org/10.1111/j.1751-1097.2007.00225.x
Abstract
The renal cell carcinoma (RCC) is extremely resistant to chemotherapy and radiotherapy. The prognosis of patients with metastatic RCC still remains poor, the median survival is less than 12 months. Therefore, new therapeutic options are desirable. The aim of this study was to investigate the photosensitizing and radiosensitizing effects of hypericin on human RCC cells in vitro. First the RCC-derived cell lines A498 and ACHN were incubated with different concentrations of hypericin. In vitro uptake and intracellular distribution of hypericin were confirmed by fluorescence microscopy. Subsequently cells were illuminated and irradiated with a dose of 2-8 Gy, respectively. Finally, metabolic activity, apoptosis and clonogenic survival were investigated. Uptake of hypericin was observed for almost all cells. Hypericin treatment combined with illumination led to a 94-97% decrease in metabolic activity and caused apoptosis in nearly 100% of RCC cells. Hypericin enhanced the radiosensitivity of A498 cells in vitro. The clonogenic survival after irradiation was significantly reduced by hypericin treatment. Taken together, the photosensitizing and radiosensitizing effects of hypericin on human RCC cells we found in this investigation could be of clinical relevance, e.g. for radiotherapy and intraoperative photodynamic therapy, respectively.Keywords
This publication has 32 references indexed in Scilit:
- Antivascular Tumor Eradication by Hypericin-mediated Photodynamic Therapy¶Photochemistry and Photobiology, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaThe New England Journal of Medicine, 2007
- Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)British Journal of Cancer, 2006
- NF-κB modulation and ionizing radiation: mechanisms and future directions for cancer treatmentCancer Letters, 2006
- Hypericum Perforatum: A ???Modern??? Herbal AntidepressantClinical Pharmacokinetics, 2006
- Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinomaInternational Journal of Cancer, 2005
- Protein kinase C-η regulates resistance to UV- and γ-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activationNeuro-Oncology, 2002
- Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor modelInternational Journal of Cancer, 2001
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- Binding, Uptake, and Transport of Hypericin by Caco-2 Cell MonolayersJournal of Pharmaceutical Sciences, 1997